Preclusion of irreversible destruction of Dr adhesin structures by a high activation barrier for the unfolding stage of the fimbrial DraE subunit.
Dr fimbriae of uropathogenic Eschericha coli strains are an example of surface-located adhesive structures assembled via the chaperone-usher pathway. These structures are crucial for specific attachment of bacteria to host receptors. Dr fimbriae are linear associates of DraE proteins, the structure of which is determined by a donor strand complementation between the consecutive subunits. The biogenesis of these structures is dependent on a function of the specific periplasmic chaperone and outer membrane usher proteins. In a consequence of these structural and assembly properties the potential unfolding of a single subunit in a linear associate would cause a destruction of fimbrial adhesion function. This correlates with the observed high resistance of fimbrial structures for denaturation. In this paper we show that the mechanism of thermal denaturation of DraE-sc protein is well described by an irreversible two-state model which is the reduced form of a Lumry-Eyring protein denaturation model. In theory of this model the observed stability of DraE-sc protein is determined by the high activation barrier for the unfolding stage N-->U. The microcalorimetry experiments permit to determine kinetic parameters of the DraE-sc unfolding process: energy of activation of 463.5 +/- 20.8 kJ.mol(-1) and rate constant of order 10(-17) s(-1). This corresponds to the dissociation/unfolding half-life of Dr fimbriae of 10(8) years at 25 degrees C. The FT-IR experiments show that the high stability of DraE is determined by the cooperative rigid protein core. The presented mechanism of kinetic stability of Dr fimbriae is probably universal to adhesive structures of the chaperone-usher type.
Piatek
Rafał
R
Department of Microbiology, Gdańsk University of Technology, Poland. wejraf@o2.pl
Bruździak
Piotr
P
Zalewska-Piatek
Beata
B
Kur
Józef
J
Stangret
Janusz
J
D018829:Adhesins, Bacterial / Q000737:chemistry* / Q000378:metabolism; D000595:Amino Acid Sequence; D004734:Energy Metabolism / Q000235:genetics; D004926:Escherichia coli / Q000737:chemistry* / Q000378:metabolism / Q000472:pathogenicity; D029968:Escherichia coli Proteins / Q000037:antagonists & inhibitors* / Q000737:chemistry* / Q000378:metabolism; D010861:Fimbriae, Bacterial / Q000737:chemistry* / Q000378:metabolism / Q000502:physiology; D007700:Kinetics; D008956:Models, Chemical; D008969:Molecular Sequence Data; D011489:Protein Denaturation / Q000502:physiology; D017510:Protein Folding; D055550:Protein Stability; D021122:Protein Subunits / Q000037:antagonists & inhibitors* / Q000737:chemistry* / Q000378:metabolism; D015398:Signal Transduction / Q000235:genetics; D017550:Spectroscopy, Fourier Transform Infrared; D013816:Thermodynamics
D018829:Adhesins, Bacterial; C465563:DraE protein, E coli; D029968:Escherichia coli Proteins; D021122:Protein Subunits